- Open Access
Correction to: What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review
© The Author(s). 2019
- Published: 24 May 2019
The original article was published in BMC Musculoskeletal Disorders 2019 20:101
Correction to: BMC Musculoskelet Disord (2019) 20:101
An incorrect attribution of the first study regarding the effect of exercise in DM1 mouse models needs to be revised.
In this article, we cited Manta et al. 2019  as the first study to publish about the effects of exercise in DM1 mouse models This was an oversight considering that Ravel-Chapuis et al. 2018  have reported in the last part of their “Results” section, presentation of the effects of wheel running on skeletal muscles of their DM1 mouse model. This article was published in October 2018 while the article of Manta et al. 2019  was published in January 2019.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Manta A, Stouth DW, Xhuti D, Chi L, Rebalka IA, Kalmar JM, et al. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice. J Physiol. 2019;597(5):1361–81.View ArticleGoogle Scholar
- Ravel-Chapuis A, Al-Rewashdy A, Belanger G, Jasmin BJ. Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles. Hum Mol Genet. 2018;27(19):3361–76.View ArticleGoogle Scholar